The largest database of trusted experimental protocols

Af1619

Manufactured by R&D Systems

AF1619 is a Recombinant Mouse Follistatin Protein. It is a glycosylated protein produced in a HEK293 cell expression system.

Automatically generated - may contain errors

2 protocols using af1619

1

Neutrophil-mediated CD8+ T cell activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
GR1+ and CD8+ T cells were isolated from the spleens of 4T1 tumor bearing mice using EasySep Mouse PE, and MojoSort™ Mouse CD8+ T Cell Isolation Kit (BioLegend, Cat# 480008), respectively. Ly6Ehi neutrophils were generated in-vitro as described above. The GR1+ cells and Ly6Ehi neutrophils (1x106/ml) were cultured in serum-free medium for 24 hours to generate conditioned medium (CM). CD8+ T cells (0.5x106/ml) were cultured with CM of GR1+ or Ly6Ehi neutrophils cells for 24 hours, after which the cells were washed and analyzed by flow cytometry for the evaluation of activated CD8+ T cells (CD8+/CD25+), effector CD8+ T cells (CD8+/CD44+/CD62L-), Granzyme B+ and Ki67+ cells. In some experiments, CD8+ T cells (0.5x106/ml) were cultured with conditioned medium of Ly6Ehi neutrophils together with neutralizing antibodies anti-IL12p40 (1μg/ml) or anti-IL23p19 (2μg/ml) (R&D systems, Cat# MAB4991 and Cat# AF1619, respectively). After 24 hours, the cells were collected, washed and analyzed by flow cytometry for the evaluation of activated CD8+ T cells (CD8+/CD25+). The experiments were performed using five biological repeats.
+ Open protocol
+ Expand
2

Murine IL-12 and IL-23 Neutralization in Tumor Immunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutralizing antibodies against murine IL-12p35 (MMp35A1.6; eBioscience) or IL-23p19 (AF1619; R&D systems) were used as previously published [13 (link)] or as prescribed on the website. Tumor-bearing C57/BL6 mice were treated via adoptive transfer of pmel-1 Tc17 cells. Beginning at 0 hours post-transfer, mice were injected intraperitoneally with 100μg neutralizing antibodies and repeated every other day for 5 cycles. The control group received isotype-matched antibody.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!